Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation

Fig. 3

Impact of HBP on LI-RADS scoring. EOB-MRI in a 53-year-old male shows a 14-mm arterial phase hyperenhancing lesion (arrow, a) within segment 5 without washout (b and c) and without T2 hyperintense signal (d) or diffusion restriction (e) but with distinct HBP hypointensity (f). The LI-RADS score was upgraded to LR-4 based on the HBP signal as an ancillary feature. The lesion was confirmed as HCC at explant histopathology. Abbreviations: CECT: contrast-enhanced computed tomography, EOB-MRI: Gadoxetate-enhanced-MRI, HCC: hepatocellular carcinoma, HBP: hepatobiliary phase, LI-RADS: Liver Imaging Reporting and Data System

Back to article page